Hopkin, R. J., Cabrera, G., Charrow, J., Lemay, R., Martins, A. M., Mauer, M., … Wilcox, W. R. (2015). Risk factors for severe clinical events and the incidence of these events in male and female patients with Fabry disease treated with agalsidase beta. In Molecular Genetics and Metabolism (Vol. 114, pp. S55–S55). Elsevier BV. https://doi.org/10.1016/j.ymgme.2014.12.114

Hopkin, Robert J., Gustavo Cabrera, Joel Charrow, Roberta Lemay, Ana Maria Martins, Michael Mauer, Alberto Ortiz, et al. “Risk factors for severe clinical events and the incidence of these events in male and female patients with Fabry disease treated with agalsidase beta.” In Molecular Genetics and Metabolism, 114:S55–S55. Elsevier BV, 2015. https://doi.org/10.1016/j.ymgme.2014.12.114.

Hopkin RJ, Cabrera G, Charrow J, Lemay R, Martins AM, Mauer M, et al. Risk factors for severe clinical events and the incidence of these events in male and female patients with Fabry disease treated with agalsidase beta. In: Molecular Genetics and Metabolism. Elsevier BV; 2015. p. S55–S55.

Hopkin, Robert J., et al. “Risk factors for severe clinical events and the incidence of these events in male and female patients with Fabry disease treated with agalsidase beta.” Molecular Genetics and Metabolism, vol. 114, no. 2, Elsevier BV, 2015, pp. S55–S55. Crossref, doi:10.1016/j.ymgme.2014.12.114.

Hopkin RJ, Cabrera G, Charrow J, Lemay R, Martins AM, Mauer M, Ortiz A, Patel MR, Sims K, Waldek S, Warnock DG, Wilcox WR. Risk factors for severe clinical events and the incidence of these events in male and female patients with Fabry disease treated with agalsidase beta. Molecular Genetics and Metabolism. Elsevier BV; 2015. p. S55–S55.